Your browser doesn't support javascript.
loading
Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy.
Bokhovchuk, Fedir; Mesrouze, Yannick; Izaac, Aude; Meyerhofer, Marco; Zimmermann, Catherine; Fontana, Patrizia; Schmelzle, Tobias; Erdmann, Dirk; Furet, Pascal; Kallen, Joerg; Chène, Patrick.
Affiliation
  • Bokhovchuk F; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Mesrouze Y; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Izaac A; Chemical Biology & Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Meyerhofer M; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Zimmermann C; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Fontana P; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Schmelzle T; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Erdmann D; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Furet P; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Kallen J; Chemical Biology & Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Chène P; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
FEBS J ; 286(12): 2381-2398, 2019 06.
Article de En | MEDLINE | ID: mdl-30903741
ABSTRACT
Four TEAD transcription factors (TEAD1-4) mediate the signalling output of the Hippo pathway that controls organ size in humans. TEAD transcriptional activity is regulated via interactions with the YAP, TAZ and VGLL proteins. A mutation in the TEAD1 gene, Tyr421His, has been identified in patients suffering from Sveinsson's chorioretinal atrophy (SCA), an autosomal dominant eye disease. This mutation prevents the YAP/TAZTEAD1 interaction. In this study, we measure the affinity of YAP, TAZ and VGLL1 for the four human TEADs and find that they have a similar affinity for all TEADs. We quantitate the effect of the mutation found in SCA patients and show that it destabilizes the YAP/TAZTEAD interaction by about 3 kcal·mol-1 . We determine the structure of YAP in complex with this mutant form of TEAD and show that the histidine residue adopts different conformations at the binding interface. The presence of this flexible residue induces the destabilization of several H-bonds and the loss of van der Waals contacts, which explains why the Tyr421HisTEAD1 mutation has such a large destabilizing effect on the formation of the YAPTEAD complex. DATABASE The crystallographic data have been deposited at the RSCB Protein Data Bank (PDB, www.pdb.org) with the access codes 6HIL (wtYAPTyr421HisTEAD1 ), 6HIK (wtYAPTyr429HisTEAD4 ).
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dégénérescence de la rétine / Facteurs de transcription / Protéines nucléaires / Dystrophies héréditaires de la cornée / Protéines du cycle cellulaire / Protéines de liaison à l'ADN / Cartes d'interactions protéiques Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: FEBS J Sujet du journal: BIOQUIMICA Année: 2019 Type de document: Article Pays d'affiliation: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dégénérescence de la rétine / Facteurs de transcription / Protéines nucléaires / Dystrophies héréditaires de la cornée / Protéines du cycle cellulaire / Protéines de liaison à l'ADN / Cartes d'interactions protéiques Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: FEBS J Sujet du journal: BIOQUIMICA Année: 2019 Type de document: Article Pays d'affiliation: Suisse